Skip to content

Study on the mechanism of castration and metabolic syndrome in prostate cancer treated by ''Hua-Tan Tong-Luo'' approach

Study on the mechanism of castration and metabolic syndrome in prostate cancer treated by ''Hua-Tan Tong-Luo'' approach

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036966
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PROSTATE CANCER

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 72 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years, male; 2. meet the western medicine diagnosis standard of "prostate cancer"; 3. meet the TCM syndrome diagnosis standard of 'deficiency of kidney Yang'; 4. agree to participate in the experiment and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) complicated with cardiovascular, liver, kidney, hematopoietic system and other serious primary diseases; (2) participate in other relevant clinical trials during the treatment period.

Design outcomes

Primary

MeasureTime frame
PSA;CRTC2;Blood lipid level;Evaluation of tumor progression;

Secondary

MeasureTime frame
TCM syndrome score;

Countries

China

Contacts

Public ContactSheng Dongya

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Shanghai University of Traditional Chinese Medicine

dongyasdy@163.com+86 18721547356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026